Effect of gonadectomy on subsequent development of age-related cognitive impairment in dogs

Journal of the American Veterinary Medical Association

Volumn 219, Issue 1, 2001, Pages 51-56

  Hart, Benjamin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

TESTOSTERONE;

AGE; ANIMAL; ANIMAL BEHAVIOR; ANIMAL DISEASE; ARTICLE; BLOOD; COGNITIVE DEFECT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE COURSE; DOG; DOG DISEASE; FEMALE; LONGITUDINAL STUDY; MALE; ORCHIECTOMY; OVARIECTOMY; PREVALENCE;

AGE FACTORS; ANIMALS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DOG DISEASES; DOGS; FEMALE; LONGITUDINAL STUDIES; MALE; ORCHIECTOMY; OVARIECTOMY; PREVALENCE; TESTOSTERONE;

EID: 0035406946     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2001.219.51     Document Type: Article

References (52)

1. Neilson JC, Hart BL, Cliff KD, et al. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001;218:1787-1791.
2. Czeschi T. Animal cognition - the phylogeny of cognitive abilities. Anim Cogn 1998;1:1-2.
3. Shettleworth SJ. Cognition, evolution and behavior. New York: Oxford University Press, 1998;3-48.
4. Cummings BJ, Head E, Ruehl WW, et al. The canine as an animal model of human aging and dementia. Neurobiol Aging 1996; 209:259-268.
5. Ruchl WW, Bruyette DS, De Paoli A, et al. Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimcr's disease: clinical presentation, cognitive testing, pathology and response to L-deprenyl therapy. Prog Brain Res 1995;106:217-225.
6. Ruchl WW, Hart BL. Canine cognitive dysfunction. In: Dodman N, Shuster L, eds. Psychopharmacology of animal behavior disorders. Malden, Mass: Blackwell Science, 1998;283-304.
7. FDA freedom of information summary, Selegiline. Exton, Pa: Pfizer Animal Health, 1998.
8. Bain MJ, Hart BL,Cliff KD, et al. Predicting behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Asoc 2001;218:1792-1795.
9. Ashford JW, Schmitt F, Kumar V. Diagnosis of Alzheimer's disease. In: Kumar V, Eisdorfer C, eds. Advances in the diagnosis and treatment of Alzheimer's disease. New York: Springer Publishing Co, 1998;111-151.
10. Frances A, Pincus HA, First MB. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1994;133-155.
11. Masur D, Silwinski M, Lipton R, et al. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994;44:1427-1432.
12. Linn R, Wolf P, Bachman D, et al. The "preclinical phase" of probable Alzheimer's disease. Arch Neurol 1995;52:485-490.
13. Bowen J, Teri L, Kukull W, et al. Progression to dementia in patients with isolated memory loss. Lancet 1997;349:763-765.
14. Jack CR, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-1403.
15. Cummings BJ, Cotman DW. Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet 1995;346:1524-1528.
16. Wisniewski H, Johnson AB, Raine CS, et al. Senile plaques and cerebral amyloidosis in aged dogs. A histochemical and ultrastructural study. Lab Invest 1970;23:287-296.
17. Uchida K, Miyauchi Y, Kakayama H, et al. Amyloid angiopathy with cerebral hemorrhage and senile plaques in aged dogs. Jpn J Vet Sci 1990;52:605-611.
18. Russell MJ, Bohik M, White RG. Age specific onset of β-amyloid in Beagle brains. Neurobiol Aging 1996;17:269-273.
19. Hou Y, White RG, Bobik M, et al. Distribution of β-amyloid in the canine brain. Neuroreport 1997;8:1009-1012.
20. Cummings B, Su JH, Colman CW, et al. β-Amyloid accumulation in aged canine brain. A model of early plaque formation in Alzheimcr's disease. Neurobiol Aging 1993;14:547-560.
21. 40 evidence from cats and dogs. Neurobiol Aging 1996;17:653-659.
22. Cummings BJ, Head E, Afagh AJ, et al. β-Amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 1996;66:11-23.
23. Head E, Callahan H, Muggenburg BA, et al. Visual-discrimination learning ability and β-amyloid accumulation in the dog. Neurobiol Aging 998;19:415-425.
24. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-1222.
25. Haskell SG, Richardson ED, Horowitz RI. The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J Clin Epidemiol 1997;11:1249-1264.
26. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 1996;156: 2213-2217.
27. Baldereschi M, Di Carlo A, Lepore V, et al. Estrogen-replacement therapy and Alzheimer's disease in the Italian longitudinal study on aging.Neurology 1998;4:996-1002.
28. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimers disease: the Baltimore longitudinal study of aging. Neurology 1997;6:1517-1521.
29. Asthana S, Craft S, Baker LD, et al. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology 1999;24:657-677.
30. Jacobs DM, Tang MX, Stern Y, et al. Cognitive function in nondemented older women with estrogen treatment after menopause. Neurology 1998;2:368-373.
31. Matthews K, Cauley J, Yaffe K, et al. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999;47:518-523.
32. Barrett-Connor E, Goodman-Gruen D, Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrionol Metab 1999;84:3681-3685.
33. Alexander GM, Swerdloff RS, Wang C, et al. Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities. Horm Behav 1998;33:85-94.
34. Gibbs RB, Burke AM, Johnson DA. Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention. Horm Behav 1998;34:112-125.
35. Luine VN. Steroid hormone modulation of hippocampal dependent spatial memory. Stress 1997;2:21-36.
36. Luine VN, Richards ST. Wu VY, et al. Estradiol enhances learning and memory in a spatial memory task and effects levels of monoaminergic neurotransmitters. Horm Behav 1998;34:149-162.
37. Packard MG. Post-training estrogen and memory modulation. Horm Behav 1998;2:126-139.
38. Packard MG, Teather LA. Post-training estradiol injections enhance memory in ovariectomized rats: cholinergic blockade and synergism. Neurobiol Learn Mem 1997;68:172-188.
39. Gibbs RB, Aggarwal P Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimers disease-related cognitive decline. Horm Behav 1998;2:98-111.
40. Woolley CS. Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus. Horm Behav 1998; 34:140-148.
41. McEwen BS, Alves SE, Bulloch K, et al. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997;48(suppl 7):8-15.
42. Stone DJ, Rozovsky I, Morgan TE. Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J Neurosci 1998; 18:3180-3185,
43. Xu H, Gouras GK, Greenfield JP, et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nature Med 1998;4:447-451.
44. Jaffe AB, Toran-Allerand CD, Greengard P, et al. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Bol Chem 1994;269:13065-13068.
45. Gouras GK, Xu H, Gross RS, et al. Testosterone reduces neuronal secretion of Alzheimer's β-amyloid peptides. Proc Natl Acad Sci U S A 2000;97:1202-1205.
46. Papasozomenos SC. The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease. Proc Natl Acad Sci U S A 1997;94:6612-6617.
47. Bishop J, Simpkins JW. Role of estrogens in peripheral and cerebral glucose utilization. Rev Neurosci 1992;3:121-137.
48. Ohkura T, Teshima Y, Isse K, et al. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 1995;2:13-218.
49. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog Neurobiol 1999;57:301-323.
50. Reosler M, Retz W, Thome J, et al. Free radicals in Alzheimer's dementia: currently available therapeutic strategies. J Neural Trans 1998;54(suppl):211-219.
51. Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol 1993;45:509-511.
52. Neilson JC, Eckstein RA, Hart BL. Effects of castration on problem behaviors in male dogs with reference to age and duration of behavior. J Am Vet Med Assoc 1997;211:180-182.